NCI Outlines Priorities for Stimulus Spending

Comparative effectiveness, pharmacogenomics, and public health genomics are among a wide array of programs NCI sees for the Recovery Act Funds.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories